Department of Anesthesiology and Reanimation, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey.
Department of Algology, Necmettin Erbakan University, Meram Faculty of Medicine, Konya, Turkey.
Agri. 2020 Nov;32(4):208-218. doi: 10.14744/agri.2020.87523.
The aim of this study was to compare the efficacy of an intercostal nerve block, which has been used for many years in the treatment of postherpetic neuralgia, and the more recent alternative of an erector spinae plane (ESP) block.
The records of 39 patients who were treated in the algology department for postherpetic neuralgia between May 1, 2015 and May 1, 2018 were evaluated retrospectively. Patients who received an intercostal nerve block constituted Group 1 and those who received an ESP block were categorized as Group 2. The change in numeric rating scale (NRS) and Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scores in the short term and in the long term were the primary results of the study.
The NRS, LANSS, and sleep interference scale (SIS) scores of the patients in Group 1 and Group 2 were found to be significantly lower at the 24th hour, week 4, and week 12 compared with the values obtained before block application. In Group 1, the scores recorded at week 4 and week 12 were significantly higher than the 24th hour values, whereas no difference was observed between these results in Group 2. There was no significant difference between the groups in the week 4 and week 12 scores. Similarly, no significant difference was observed in the NRS, LANSS, or SIS scores before the block application or at the 24th hour. However, the scores at week 4 and week 12 were significantly lower in Group 2 compared with Group 1.
The results indicated that an ESP block significantly decreased neuropathic pain symptoms and the need for additional treatment in postherpetic neuralgia treatment in the long term.
本研究旨在比较肋间神经阻滞与最近出现的竖脊肌平面（ESP）阻滞在治疗带状疱疹后神经痛方面的疗效。
回顾性分析 2015 年 5 月 1 日至 2018 年 5 月 1 日在疼痛科接受带状疱疹后神经痛治疗的 39 例患者的病历。接受肋间神经阻滞的患者为 1 组，接受 ESP 阻滞的患者为 2 组。本研究的主要结果是短期和长期内数字评分量表（NRS）和 Leeds 评估神经性症状和体征（LANSS）评分的变化。
与阻滞前相比，1 组和 2 组患者的 NRS、LANSS 和睡眠干扰量表（SIS）评分在 24 小时、第 4 周和第 12 周均显著降低。1 组在第 4 周和第 12 周的评分明显高于 24 小时的评分，而 2 组之间的评分没有差异。两组在第 4 周和第 12 周的评分之间无显著差异。同样，两组在阻滞前或 24 小时的 NRS、LANSS 或 SIS 评分无显著差异。然而，2 组在第 4 周和第 12 周的评分明显低于 1 组。
结果表明，ESP 阻滞在带状疱疹后神经痛的长期治疗中可显著减轻神经病理性疼痛症状和对额外治疗的需求。
